Webinars
Webinar-Preparing for Phase 1: Strategies for Success in Advancing your Drug to First-in-Human Trials
Summary: During this webinar, biopharma R&D professionals will review strategies for moving successfully and efficiently from preclinical studies to first-in-human trials. They will call upon their own experiences to provide advice that will help others in the industry navigate this crucial transition.
View Now
Webinars
Highly Potent API Drug Product Development and Manufacturing Using Micronization Technology
Summary: This webinar will discuss how to classify HPAPIs in early development and share recommendations for safe product handling, from clinical manufacturing to commercialization.
View Now
Offering Fact Sheet
Micronization Technology Solutions From Early Phase Development to Commercial Scale Manufacturing
Summary: Catalent is a global leader in pharmaceutical air jet milling micronization with more than 30 years’ experience delivering micronization solutions.
View Now
Webinars
Concept to Dosing-Challenges in New Orphan Drugs
Summary: In this webinar a group of experienced cancer drug developers discusses key strategies in managing an orphan drug program.
View Now
Webinars
A Guide to Drug Development of Challenging Molecules
Summary: This webinar discusses, key considerations of early drug development, molecule developability assessment, drug bioavailability and discussed the relationship between intracellular and transcellular permeability of beyond the Rule of Five drugs.
View Now
Webinars
Effective Scale-Up and Technology Transfer Strategies for Spray Dried Pharma Products
Summary: In this webinar, learn from real world case studies about best practices and strategies to mitigate risks and ensure a successful tech transfer from development through to commercial scale spray drying of pharmaceutical products.
View Now
eBook
Pharmaceutical Outsourcing for Oral Development and Manufacturing
Summary: This eBook includes an overview of outsourcing trends in the oral solid dose market. Featured articles describe the robust market resulting from the demand for specialized dosage forms such as controlled release, pediatric and geriatric delivery vehicles.
View Now
Article
Selecting the Most Suitable Dosage Form Technology for the Oral Delivery of Lipid-Based Formulations
Summary: Lipid-based drug delivery systems have found widespread acceptance for development of drug products containing developability challenged APIs.
View Now
Infographic
Boosting Bioavailability- How Companies are Using Advanced Technologies to Formulate Complex Molecules
Summary: This infographic focuses on evolving technologies that help overcome bioavailability challenges enabling the formulation of more complex molecules.
View Now
Case Study
Improving Bioavailability Using PBPK Modeling & Parallel Formulation Screening
Read this case study to learn how a team of bioavailability experts at Catalent took a target molecule from early stage to Phase 1 in under nine months.
View Now